Medtronic Manipulated Bone Device Studies, Report Says
Medical device maker Medtronic Inc. may have manipulated company-sponsored health studies of its Infuse bone-growth product by editing the published content and paying doctors and researchers $210 million over 15 years...To view the full article, register now.
Already a subscriber? Click here to view full article